Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · IEX Real-Time Price · USD
1.630
-0.010 (-0.61%)
Jul 19, 2024, 12:00 AM EDT - Market open
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 13 employees as of December 31, 2023. The number of employees decreased by 2 or -13.33% compared to the previous year.
Employees
13
Change (1Y)
-2
Growth (1Y)
-13.33%
Revenue / Employee
n/a
Profits / Employee
-$755,833
Market Cap
4.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
IM Cannabis | 95 |
Sharps Technology | 57 |
Intelligent Bio Solutions | 51 |
Theriva Biologics | 22 |
Adial Pharmaceuticals | 7 |
Portage Biotech | 7 |
Artelo Biosciences | 6 |
Creative Medical Technology Holdings | 4 |
PCSA News
- 5 weeks ago - Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research - GlobeNewsWire
- 4 months ago - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - GlobeNewsWire
- 4 months ago - Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 5 months ago - Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference - GlobeNewsWire
- 5 months ago - Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference - GlobeNewsWire
- 5 months ago - Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule - GlobeNewsWire